COVID-19 and Gastrointestinal Disease: Current Insights and Future Management
- PMID: 37048810
- PMCID: PMC10094869
- DOI: 10.3390/jcm12072727
COVID-19 and Gastrointestinal Disease: Current Insights and Future Management
Abstract
The first case of coronavirus disease 2019 (COVID-19) was reported in Wuhan, Hubei Province, China, in December 2019, marking a pivotal moment in human history [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Ecological Study on Differences in COVID-19 Fatality among Wuhan, Rest of Hubei, and Rest of China.J Epidemiol Glob Health. 2021 Mar;11(1):42-45. doi: 10.2991/jegh.k.200902.001. Epub 2020 Sep 10. J Epidemiol Glob Health. 2021. PMID: 33009735 Free PMC article.
-
Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China.Clin Epidemiol. 2020 Jul 2;12:699-709. doi: 10.2147/CLEP.S254806. eCollection 2020. Clin Epidemiol. 2020. PMID: 32669878 Free PMC article.
-
Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.Infect Dis Poverty. 2020 Aug 24;9(1):116. doi: 10.1186/s40249-020-00683-6. Infect Dis Poverty. 2020. PMID: 32831142 Free PMC article.
-
Gastrointestinal and Liver Manifestations in COVID-19 Population.Middle East J Dig Dis. 2021 Oct;13(4):281-286. doi: 10.34172/mejdd.2021.236. Epub 2021 Sep 3. Middle East J Dig Dis. 2021. PMID: 36606012 Free PMC article. Review.
-
[Guide for the prevention and treatment of coronavirus disease 2019].Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):473-489. doi: 10.3760/cma.j.cn112147-112147-20200321-00392. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 32486556 Review. Chinese.
References
-
- Zelenika M., Lucijanic M., Bokun T., Bozin T., Barisic Jaman M., Tjesic Drinkovic I., Pastrovic F., Madir A., Luksic I., Piskac Zivkovic N., et al. FibroScan-AST Score Predicts 30-Day Mortality or Need for Mechanical Ventilation among Patients Hospitalized with COVID-19. J. Clin. Med. 2021;10:4355. doi: 10.3390/jcm10194355. - DOI - PMC - PubMed
-
- Pausawasdi N., Manomaiwong E., Kaosombatwattana U., Karaketklang K., Charatcharoenwitthaya P. The Effects of COVID-19 on Clinical Outcomes of Non-COVID-19 Patients Hospitalized for Upper Gastrointestinal Bleeding during the Pandemic. J. Clin. Med. 2022;11:2461. doi: 10.3390/jcm11092461. - DOI - PMC - PubMed
-
- Kaliszewski K., Diakowska D., Nowak Ł., Tokarczyk U., Sroczyński M., Sępek M., Dudek A., Sutkowska-Stępień K., Kiliś-Pstrusińska K., Matera-Witkiewicz A., et al. Assessment of Gastrointestinal Symptoms and Dyspnea in Patients Hospitalized due to COVID-19: Contribution to Clinical Course and Mortality. J. Clin. Med. 2022;11:1821. doi: 10.3390/jcm11071821. - DOI - PMC - PubMed
-
- Zabana Y., Marín-Jiménez I., Rodríguez-Lago I., Vera I., Martín-Arranz M.D., Guerra I., Gisbert J.P., Mesonero F., Benítez O., Taxonera C., et al. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry. J. Clin. Med. 2022;11:421. doi: 10.3390/jcm11020421. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources